US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.5819
  • -0.0381-6.15%
Close Nov 1 16:00 ET
  • 0.5601
  • -0.0218-3.75%
Post 20:01 ET
2.92MMarket Cap-105P/E (TTM)

About Matinas BioPharma Company

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Company Profile

SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees32
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805
Websitehttp://www.matinasbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jerome D. Jabbour, J.D.
  • Chief Executive Officer, President and Director
  • 1.67M
  • Keith A. Kucinski, C.P.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Eric J. Ende, M.B.A.,M.D.
  • Chairman of the Board
  • 151.50K
  • Kathryn Penkus Corzo, M.B.A.,R.Ph.
  • Independent Director
  • 136.00K
  • Herbert J. Conrad
  • Independent Director
  • 170.50K
  • Natasha Giordano
  • Independent Director
  • 137.50K
  • Dr. Matthew A. Wikler, M.B.A.,M.D.
  • Independent Director
  • 144.00K
  • James S. Scibetta, M.B.A.
  • Independent Director
  • 155.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data